Cargando…

Guillain–Barrè syndrome following COVID-19 vaccine mRNA-1273: a case report

Detalles Bibliográficos
Autores principales:	Masuccio, Fabio Giuseppe, Comi, Cristoforo, Solaro, Claudio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586608/ https://www.ncbi.nlm.nih.gov/pubmed/34767184 http://dx.doi.org/10.1007/s13760-021-01838-4

Ejemplares similares

Motor and non-motor symptom improvement after mRNA-1273 vaccine in a Parkinson’s disease patient
por: Contaldi, Elena, et al.
Publicado: (2021)

mRNA-1273: Guillain-Barre syndrome: case report
Publicado: (2021)

Role of an intensive inpatient rehabilitation program in functional recovery after guillain-barre’ Syndrome related or not to COVID-19
por: Marcello Solaro, Claudio, et al.
Publicado: (2021)

Sub-acute Onset of Guillain-Barré Syndrome Post-mRNA-1273 Vaccination: a Case Report
por: Nagalli, Shivaraj, et al.
Publicado: (2022)

Guillain‐Barré syndrome after mRNA‐1273 (Moderna) COVID‐19 vaccination: A case report
por: Anjum, Zauraiz, et al.
Publicado: (2022)

Parsonage Turner Syndrome Following Vaccination With mRNA-1273 SARS-CoV-2 Vaccine
por: Bernheimer, James H., et al.
Publicado: (2022)

De novo vasculitis after mRNA-1273 (Moderna) vaccination
por: Anderegg, Manuel A., et al.
Publicado: (2021)

Minimal change disease following the Moderna mRNA-1273 SARS-CoV-2 vaccine
por: Holzworth, Amy, et al.
Publicado: (2021)

Two possible etiologies of Guillain-Barré syndrome: mRNA-1273 (Moderna) vaccination and scrub typhus: A case report
por: Hwang, Byoung Wook, et al.
Publicado: (2022)

Vaccine-induced immune thrombocytopenia and thrombosis after mRNA-1273 booster vaccination
por: Langerak, T., et al.
Publicado: (2022)

Small-Fiber Neuropathy After Vaccination With mRNA-1273 SARS-CoV-2 Vaccine
por: Bernheimer, James H., et al.
Publicado: (2023)

Re: Heterologous Gam-COVID-Vac (Sputnik V)/mRNA-1273 (Moderna) vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Pityriasis rosea after Moderna mRNA‐1273 vaccine: A case series
por: Martora, Fabrizio, et al.
Publicado: (2021)

Humoral response of the mRNA-1273 SARS-CoV-2 vaccine in peritoneal dialysis patients
por: Rodríguez-Espinosa, Diana, et al.
Publicado: (2021)

Heterologous Gam-COVID-Vac (Sputnik V)/mRNA-1273 (Moderna) vaccination: Author's response
por: Pereson, Matías J., et al.
Publicado: (2022)

Myocarditis following COVID‐19 mRNA (mRNA‐1273) vaccination
por: Chellapandian, Suresh Babu, et al.
Publicado: (2022)

Association Between Fever and Antibody Titer Trends After a Third Dose of the mRNA-1273 Vaccine
por: Matsumoto, Naomi, et al.
Publicado: (2022)

Guillain-Barré Syndrome Associated with COVID-19 Vaccination
por: Finsterer, Josef, et al.
Publicado: (2022)

Guillain–Barré syndrome associated with vaccines in Veracruz, Mexico
por: Carpio-Orantes, Luis Del, et al.
Publicado: (2022)

Successful alternative vaccination with BNT162b2 mRNA COVID-19 vaccine for new-onset IgA vasculitis after receiving mRNA-1273—case report
por: Morioka, Fumiyuki, et al.
Publicado: (2022)

Comparison of BNT162b2 (Pfizer–BioNtech) and mRNA-1273 (Moderna) SARS-CoV-2 mRNA vaccine immunogenicity in dialysis patients
por: Kaiser, Robert A., et al.
Publicado: (2021)

Bullous Pemphigoid Following the Moderna mRNA-1273 Vaccine
por: Desai, Amar D, et al.
Publicado: (2022)

Vasculitic flare in a patient with anti-myelin-associated glycoprotein (MAG) antibody following mRNA-1273 SARS-CoV-2 vaccine
por: Briani, Chiara, et al.
Publicado: (2022)

Guillain-Barré syndrome following COVID-19: new infection, old complication?
por: Padroni, Marina, et al.
Publicado: (2020)

Guillain-Barré syndrome following acute viral hepatitis A
por: Menon, Deepak, et al.
Publicado: (2014)

Outbreak of Guillain-Barre syndrome in Peru
por: Díaz-Soto, S., et al.
Publicado: (2019)

COVID-19 and Guillain-Barré syndrome
por: Joob, B., et al.
Publicado: (2020)

Guillain-Barre Syndrome, Facial Diplegia, and Pfizer COVID-19 Vaccine
Publicado: (2022)

Distinct glomerular disease association after vaccination with BNT162b2 and mRNA-1273: a VigiBase analysis
por: Kronbichler, Andreas, et al.
Publicado: (2022)

Guillain-Barre' Syndrome Following Scrub Typhus: A Rare Case
por: Pandey, Shishir, et al.
Publicado: (2021)

Guillain-Barré syndrome and fulminant encephalomyelitis following Ad26.COV2.S vaccination: double jeopardy
por: Stefanou, Maria Ioanna, et al.
Publicado: (2022)

Acute Myocarditis Following Vaccination With the First Dose of the mRNA-1273 Vaccine
por: Olagunju, Abdulbaril, et al.
Publicado: (2022)

(1197) Guillain-Barré Syndrome after Mrna-1273 Covid-19 Vaccine Booster in an Immunosuppressed Double Lung Transplant Recipient
por: Sindu, D., et al.
Publicado: (2023)

Guillain-Barré or Guillain-Barré-Strohl syndrome: medical and non-medical reasons for omitting Andre Strohl from the eponym
por: Rzepiński, Łukasz, et al.
Publicado: (2022)

Correspondence Regarding “Tolerability of Coronavirus Disease 2019 Vaccines BNT162b2 and mRNA-1273 in Patients With Thymic Epithelial Tumors”
por: Takada, Kazuki, et al.
Publicado: (2021)

Post-adenoviral-based vaccines Guillain-Barre Syndrome: A proposed mechanism
por: Kadkhoda, Kamran
Publicado: (2022)

Guillain-Barré Syndrome after Chikungunya Infection
por: Lebrun, Gaëtan, et al.
Publicado: (2009)

Lyme polyradiculitis masquerading Guillain-Barre syndrome
por: Kumar, Mritunjay, et al.
Publicado: (2016)

COVID-19 and Guillain-Barré syndrome: Response()
por: Camdessanché, Jean-Philippe, et al.
Publicado: (2020)

Post Covid-19 Guillain Barre Syndrome
por: Maramattom, Boby Varkey, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8vl3ksr329ve2ahkft7f20m2dv